CVALF (Covalon Technologies) Cyclically Adjusted Revenue per Share: $0.87 (As of Mar. 2026)


CVALF Covalon Technologies Ltd CVALF
83 GF Score
Price $1.51
GF Value $1.53
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Covalon Technologies Cyclically Adjusted Revenue per Share?

Covalon Technologies CVALF -1.79% 83 Cyclically Adjusted Revenue per Share is $0.87 as of Mar. 2026. GuruFocus rates CVALF with a GF Score™ of 83/100 and a GF Value™ of $1.53 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Covalon Technologies's adjusted revenue per share for the three months ended in Mar. 2026 was $0.229. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.87 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Covalon Technologies's average Cyclically Adjusted Revenue Growth Rate was 3.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Covalon Technologies was 20.30% per year. The lowest was 5.00% per year. And the median was 9.20% per year.

As of today (2026-07-09), Covalon Technologies's current stock price is $1.51. Covalon Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $0.87. Covalon Technologies's Cyclically Adjusted PS Ratio of today is 1.74.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Covalon Technologies was 12.75. The lowest was 0.86. And the median was 2.25.


Covalon Technologies  (OTCPK:CVALF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Covalon Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.51/0.87
=1.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Covalon Technologies was 12.75. The lowest was 0.86. And the median was 2.25.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Covalon Technologies Cyclically Adjusted Revenue per Share Related Terms


Covalon Technologies Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Covalon Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies Cyclically Adjusted Revenue per Share Chart

Covalon Technologies Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 0.77 0.75 0.86 0.86

Covalon Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.89 0.86 0.83 0.87

CVALF vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Covalon Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Covalon Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Cyclically Adjusted PS Ratio falls into.


CVALF
83GF Score
Covalon Technologies Ltd CVALF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Covalon Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Covalon Technologies's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.229/132.2623*132.2623
=0.229

Current CPI (Mar. 2026) = 132.2623.

Covalon Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.140 102.002 0.182
201609 0.035 101.765 0.045
201612 0.356 101.449 0.464
201703 0.189 102.634 0.244
201706 0.164 103.029 0.211
201709 0.498 103.345 0.637
201712 0.234 103.345 0.299
201803 0.185 105.004 0.233
201806 0.247 105.557 0.309
201809 0.183 105.636 0.229
201812 0.243 105.399 0.305
201903 0.449 106.979 0.555
201906 0.232 107.690 0.285
201909 0.214 107.611 0.263
201912 0.234 107.769 0.287
202003 0.146 107.927 0.179
202006 0.191 108.401 0.233
202009 -0.187 108.164 -0.229
202012 0.079 108.559 0.096
202103 0.132 110.298 0.158
202106 0.191 111.720 0.226
202109 0.202 112.905 0.237
202112 0.149 113.774 0.173
202203 0.100 117.646 0.112
202206 0.142 120.806 0.155
202209 0.159 120.648 0.174
202212 0.181 120.964 0.198
202303 0.212 122.702 0.229
202306 0.189 124.203 0.201
202309 0.207 125.230 0.219
202312 0.141 125.072 0.149
202403 0.252 126.258 0.264
202406 0.273 127.522 0.283
202409 0.254 127.285 0.264
202412 0.204 127.364 0.212
202503 0.189 129.181 0.194
202506 0.219 129.892 0.223
202509 0.227 130.287 0.230
202512 0.180 130.366 0.183
202603 0.229 132.262 0.229

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.87 mean?
Covalon Technologies (CVALF) has a Cyclically Adjusted Revenue per Share of $0.87 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Covalon Technologies and its competitors.
Is Covalon Technologies' Cyclically Adjusted Revenue per Share too high?
Covalon Technologies' current Cyclically Adjusted Revenue per Share is $0.87. Overall, Covalon Technologies has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Covalon Technologies' Cyclically Adjusted Revenue per Share of $0.87 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Covalon Technologies and its competitors. Covalon Technologies's current Cyclically Adjusted Revenue per Share is $0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Fairly Valued. The stock's GF Value™ is $1.53, compared to a current price of $1.51 — trading 1.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.87. Covalon Technologies' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current Cyclically Adjusted Revenue per Share is $0.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be undervalued. The current stock price of $1.51 is trading 1.3% below its estimated GF Value™ of $1.53. GuruFocus considers Covalon Technologies to be Fairly Valued.

Key valuation signals for CVALF:

  • Cyclically Adjusted Revenue per Share: $0.87
  • GF Value™: $1.53 vs. price of $1.51 (1.3% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
83GF Score

Get the complete analysis for CVALF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.51
Price
$1.53
GF Value